Talking about Lung and Pancreatic Cancers
November marks the start of two separate month long awareness campaigns, for lung cancer and pancreatic cancer. Two cancers which seem very different, but which are similar in some very important ways. And both desperately need more research.
Both lung cancer and pancreatic cancer have woefully low survival rates compared to some other cancers, and both types of cancer tend to be diagnosed late, when less can be done. Smoking can also be a major cause of both cancers- accounting for 8 in 10 lung cancer cases and almost 3 in 10 pancreatic cancers.
More research will improve this situation, and advances in prevention, diagnosis and treatment are already improving the lives of patients. But in general, research into lung cancer and pancreatic cancer is still relatively underfunded compared to some other types of cancer.
Worldwide Cancer Research does not discriminate between cancer types, and we currently have several researchers around the world tackling pancreatic and lung cancer. Researchers like:
Dr Sharon Rossiter in the UK who is using computer based drug design to find potential new compounds to treat pancreatic ductal adenocarcinoma (PDAC).
Professor Marc Vooijs in the Netherlands, who is trying to find ways to improve standard treatment for non-small cell lung cancer.
Dr Kate Sutherland in Australia who is identifying gene mutations that drive lung squamous cell carcinoma.
See our world map for more information about other projects we are funding which aim to improve diagnosis and treatment of lung and pancreatic cancer.